Study: Fenbendazole Can Cure Cancer

Simian Practicalist
Aug 19
1 min read

Updated: Aug 22

Given the colorful discussions in the past few years regarding Ivermectin for treating COVID-19, its application to cancer treatment has also come to the fore.

And Ivermectin is not the only inexpensive antiparasitic drug that can be applied to cancer treatment. It seems Fenbendazole (FBZ), a benzimidazole anthelmintic for human and veterinary, may also work on cancer.

A case report by W. Makis et al titled “Fenbendazole as an Anticancer Agent? A Case Series of Self-Administration in Three Patients” posted on 26 May briefly discusses these three cancer patients.

Although the sample is small, all were elderly and at stage IV:

Case 1 – An 83-year-old female with breast cancer.
Case 2 – A 75-year-old male with recurrent prostate cancer and extensive bone metastases.
Case 3 – A 63-year-old male with melanoma.

The study does not have the rigor of a clinical trial since all three began using FBZ on their own after having rejected standard treatment such as chemo. In the first two cases, they also took supplements such as vitamin D, so any interaction with FBZ is not known exactly.

Nonetheless, the significance of these three cases is that even for three elderly cancer patients in serious condition, two cases achieved complete remission and the 75-year-old male with recurrent prostate cancer achieved near-complete remission at 222–444 mg/day of FBZ and without chemo.